MedPath

Aripiprazole

ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS

Approved
Approval ID

0f9b1fd8-a648-45c9-8655-14de07439f34

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 2, 2023

Manufacturers
FDA

SQUARE PHARMACEUTICALS LIMITED

DUNS: 731487153

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aripiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76483-103
Application NumberANDA090165
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aripiprazole
Product Specifications
Route of AdministrationORAL
Effective DateJuly 2, 2023
FDA Product Classification

INGREDIENTS (6)

CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
ARIPIPRAZOLEActive
Quantity: 30 mg in 1 1
Code: 82VFR53I78
Classification: ACTIB
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
PEPPERMINTInactive
Code: V95R5KMY2B
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT

Aripiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76483-101
Application NumberANDA090165
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aripiprazole
Product Specifications
Route of AdministrationORAL
Effective DateJuly 2, 2023
FDA Product Classification

INGREDIENTS (6)

ARIPIPRAZOLEActive
Quantity: 15 mg in 1 1
Code: 82VFR53I78
Classification: ACTIB
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
PEPPERMINTInactive
Code: V95R5KMY2B
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

Aripiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76483-100
Application NumberANDA090165
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aripiprazole
Product Specifications
Route of AdministrationORAL
Effective DateJuly 2, 2023
FDA Product Classification

INGREDIENTS (6)

ARIPIPRAZOLEActive
Quantity: 10 mg in 1 1
Code: 82VFR53I78
Classification: ACTIB
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
PEPPERMINTInactive
Code: V95R5KMY2B
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

Aripiprazole

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76483-102
Application NumberANDA090165
Product Classification
M
Marketing Category
C73584
G
Generic Name
Aripiprazole
Product Specifications
Route of AdministrationORAL
Effective DateJuly 2, 2023
FDA Product Classification

INGREDIENTS (6)

ARIPIPRAZOLEActive
Quantity: 20 mg in 1 1
Code: 82VFR53I78
Classification: ACTIB
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
PEPPERMINTInactive
Code: V95R5KMY2B
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/15/2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.